Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 655 participants.
Also called NCT00971165
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 655 participants
- Registry
-
NCT00971165
-
- Other papers using this trial's data
- Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial
- Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension: results from the PREVER-treatment randomized trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Brazil
- Registry status
- Completed
Technical summary
Registry record NCT00971165. Randomized; quadruple masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2014-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I Hypertension
- Acronym
- PREVER
- Condition
- Hypertension
- Condition
- Cardiovascular Disease
- Intervention (Drug)
- losartan
- Intervention (Drug)
- Chlorthalidone plus amiloride
- Lead sponsor
- Hospital de Clinicas de Porto Alegre
- Collaborator
- Financiadora de Estudos e Projetos
Record details
- Record id
cardio:ct-nct00971165- Content hash
0a517b945edf743e23b5b3b4eab543fc03bea9ddfd41055843dd4a0f70b5d53d